Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2023 32.13M
March 31, 2023 32.13M
December 31, 2022 32.13M
September 30, 2022 32.13M
June 30, 2022 32.13M
March 31, 2022 32.13M
December 31, 2021 11.77M
September 30, 2021 0.1277M
June 30, 2021 7.102M
March 31, 2021 6.724M
December 31, 2020 2.475M
September 30, 2020 0.5399M
June 30, 2020 0.0667M
March 31, 2020 0.0667M
December 31, 2019 0.0083M
September 30, 2019 0.0001M
June 30, 2019 0.0027M
March 31, 2019 0.0027M
December 31, 2018 0.0015M
September 30, 2018 0.0004M
June 30, 2018 0.0003M
March 31, 2018 0.0002M
December 31, 2017 0.0002M
September 30, 2017 0.0002M
June 30, 2017 0.00
Date Value
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 0.00
June 30, 2013 0.00
March 31, 2013 0.00
December 31, 2012 0.00
September 30, 2012 0.00
June 30, 2012 0.00
March 31, 2012 0.00
December 31, 2011 0.00
September 30, 2011 0.00
June 30, 2011 0.00
March 31, 2011 0.00

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M
Savara, Inc. 205.40M
Vericel Corp. 51.17M
Biogen, Inc. 147.70M